In GSCs with wtp53, the transcriptional response induced by ClQ is primarily determined by p53-dependent transcriptional repression via the p53-p21-DREAM pathway [66,68] and p53-dependent transcriptional activation of glioma-promoting genes from the mevalonate pathway [70,71]. The gene discussed is KCNIP3; the disease is glioma.